HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to participate in the upcoming Piper Sandler 38th Annual Healthcare Conference in New York, NY. Pulse Biosciences’ Management is scheduled to present on Thursday, December 3, at 8:50 am ET. A live and recorded webcast of the presentation will be available on the “Events Ca